Investor Relations 2018-07-18T12:01:51+00:00

Stock Information

News & Press Release

Brad Rogers on Company Undervaluation and Annual...

By | July 18th, 2018|Categories: CannTrust News, Industry News, Second Home|Tags: , , , , , , , , , , , , |

VIDEO: CannTrust Holdings Inc (TSE:TRST) COO on Company Undervaluation and Annual Profits MIDASLETTER LIVE CannTrust Holdings Inc (TSE:TRST | OTCMKTS:CNTTF | FRA:C9S) COO Brad Rogers discusses the company’s three part [...]

CannTrust Goes West! CannTrust’s Three Recreational Supply...

By | July 13th, 2018|Categories: CannTrust News, Press Release, Second Home|Tags: , , , , , , , , , , , , , , |

VAUGHAN, ON, July 13, 2018 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST), one of Canada's leading licensed producers of cannabis, explodes into the adult use market with [...]

CannTrust and Australia’s Gold Coast University Hospital...

By | July 11th, 2018|Categories: CannTrust News, Press Release, Second Home|Tags: , , , , , , , , , , , , , , , , |

The study is designed to evaluate the efficacy of CannTrust's Cannabidiol Oil Capsules in slowing Amyotrophic Lateral Sclerosis (ALS) progression VAUGHAN, ON, July 11, 2018 /CNW/ - CannTrust [...]

Annual Reports and Financial Information

Quarterly Reports

Annual General Meeting

Analysts

Firm Analyst Email Address Phone #
BLOOM BURTON  DAVID MARTIN dmartin@bloomburton.com  416-642-8865
CANACCORD GENUITY  NEIL MARUOKA nmaruoka@canaccordgenuity.com  416-869-3073
EIGHT CAPITAL  DANIEL PEARLSTEIN dpearlstein@viiicapital.com  647-253-1160
ECHELON WEALTH PARTNERS  RUSSELL STANLEY rstanley@echelonpartners.com  647-794-1922
HAYWOOD SECURITIES INC.  NEAL GILMER ngilmer@haywood.com  416-507-2759
GMP SECURITIES MARTIN LANDRY mlandry@gmpsecurities.com  514-288-4016

FAQ

TEXT FAQ

Q: What is your stock symbol?

A: TRST

Q: Who is CannTrust’s transfer agent?

A: CannTrust’s transfer agent is TSX Trust Company.

Q: When is CannTrust’s fiscal year end?

A: CannTrust’s fiscal year ends on December 31 st.

Q: On what stock exchange does CannTrust’s shares trade?

A: CannTrust’s shares trade on the Toronto Stock Exchange.

Q: How many shares are outstanding?

A: 92+ million shares

Q: How many patients does CannTrust have?

A: CannTrust has over 46,000 patients.

Q: Has CannTrust ever had any products recalled?

A: No. We grow to the highest standards, sells completely pesticide free product and have not had any product recalls as a result.

Q: How can I get access to CannTrust’s financial statements?

A: CannTrust’s financial statements can be found by searching CannTrust Holding Inc. at sedar.com. CannTrust’s financial statements can also be found on our investor page above.

Q: How much of the company do founders/insiders/management/board own?

A: Approx. 40% is owned by this group – as at September 30, 2017.

Q: Is there a lockup on these shareholders?

A: Yes, in order to create an orderly transition to becoming a public company, the founders and insiders entered into a voluntary lockup that sees the shares become released over time.

Q: What do I do if I lost my share certificate?

A:If you have lost your share certificate, please feel free to contact TSX Trust, CannTrust’s transfer agent at https://www.tsxtrust.com/.

Q: When is your next Annual General Meeting?

A: We will announce our Annual General Meeting via press release and all related documents will be posted to sedar.com.

Q: How do I vote my shares?

A:Unless you have otherwise opted out, you will receive a Form of Proxy in the mail prior to the Annual General Meeting. The form will include instructions detailing call-in or online voting. Please ensure your vote is cast before the deadline outlined on the form.

Company Information

Contact CannTrust

For all investor enquiries, please contact us directly at:

CannTrust Inc.
Email: investor@canntrust.ca
Phone: 1-855-794-2266 Ext. 2703

For all changes of address and registration enquiries, please contact our transfer agent.